Skip to main content

Pharmacodynamic and predictive biomarkers for IO from preclinical to clinical stages

18 Jun 2024
Immune Biomarkers
  • How can we best incorporate pharmacodynamic biomarkers to guide clinical strategy?
  • What approaches represent the future of predictive biomarkers in the IO space?
  • How can we best design clinical biomarker studies to drive better reverse translation?
Industry Expert
Dan Felitsky, President and CSO - Sfida Ventures